Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study: could physical therapy boost hip injection results?

NCT ID NCT06653985

Symptom relief Sponsor: ArthroBiologix Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether adding physiotherapy to a hip injection (corticosteroid plus hyaluronic acid) helps reduce pain and improve function more than the injection alone. It includes 100 adults aged 40-60 with mild hip arthritis, labral tears, or hip impingement. Participants will receive either the injection plus physiotherapy or the injection alone, and their progress will be tracked over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2024

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients aged 40-60 years old. 2. Patients with mild hip arthritis (Kellgren-Lawrence grade 2 or lower) with or without a labral tear and/or femoroacetabular impingement and/or mild hip dysplasia. 3. Patients who demonstrate more than 50% reduction in hip pain following a diagnostic injection (ultrasound guided intra-articular anaesthetic only). 4. Able to subsidize private physiotherapy services. 5. Able to provide informed consent. Exclusion Criteria: 1. Active infection 2. Osteonecrosis of the hip, moderate to severe arthritis (Kellgren-Lawrence grade 3 or higher), or moderate-to-severe hip dysplasia 3. Previous hip fracture, pelvic fracture, or lower limb fracture, 4. Previous surgery to the pelvis, hip or lower limb 5. Hypermobility disorder or connective tissue disease (e.g. Ehler's-Danlos syndrome, Marfan's syndrome etc.) 6. Patients with chronic low back pain and/or sciatica 7. Patients who received an intra-articular steroid hip injection within 3 months 8. Patients who have previously received a hyaluronic acid injection 9. Injuries sustained in a motor vehicle collision. 10. Injuries sustained in the workplace and have a worker's compensation claim. 11. Injuries resulting in a medico-legal dispute. 12. Patients who are pregnant of planning to become pregnant 13. Currently enrolled in a study that does not permit co-enrollment 14. Unable to obtain informed consent 15. Unable to comply with the study protocol 16. Contraindication to corticosteroid or hyaluronic acid injection 17. Prior enrollment in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Femoroacetabular impingement syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Femoracetabular Impingement osteoarthritis osteoarthritis, hip

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Femoroacetabular impingement syndrome Labrum injury of the hip joint Osteoarthritis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • ArthroBiologix

    RECRUITING

    Hamilton, Ontario, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.